Correlation Between Emerging Markets and Pharmaceuticals Portfolio
Can any of the company-specific risk be diversified away by investing in both Emerging Markets and Pharmaceuticals Portfolio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emerging Markets and Pharmaceuticals Portfolio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emerging Markets Sustainability and Pharmaceuticals Portfolio Pharmaceuticals, you can compare the effects of market volatilities on Emerging Markets and Pharmaceuticals Portfolio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emerging Markets with a short position of Pharmaceuticals Portfolio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emerging Markets and Pharmaceuticals Portfolio.
Diversification Opportunities for Emerging Markets and Pharmaceuticals Portfolio
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Emerging and Pharmaceuticals is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Emerging Markets Sustainabilit and Pharmaceuticals Portfolio Phar in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Portfolio and Emerging Markets is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emerging Markets Sustainability are associated (or correlated) with Pharmaceuticals Portfolio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Portfolio has no effect on the direction of Emerging Markets i.e., Emerging Markets and Pharmaceuticals Portfolio go up and down completely randomly.
Pair Corralation between Emerging Markets and Pharmaceuticals Portfolio
Assuming the 90 days horizon Emerging Markets Sustainability is expected to under-perform the Pharmaceuticals Portfolio. But the mutual fund apears to be less risky and, when comparing its historical volatility, Emerging Markets Sustainability is 1.11 times less risky than Pharmaceuticals Portfolio. The mutual fund trades about -0.01 of its potential returns per unit of risk. The Pharmaceuticals Portfolio Pharmaceuticals is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest 2,820 in Pharmaceuticals Portfolio Pharmaceuticals on September 1, 2025 and sell it today you would earn a total of 404.00 from holding Pharmaceuticals Portfolio Pharmaceuticals or generate 14.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Emerging Markets Sustainabilit vs. Pharmaceuticals Portfolio Phar
Performance |
| Timeline |
| Emerging Markets Sus |
| Pharmaceuticals Portfolio |
Emerging Markets and Pharmaceuticals Portfolio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Emerging Markets and Pharmaceuticals Portfolio
The main advantage of trading using opposite Emerging Markets and Pharmaceuticals Portfolio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emerging Markets position performs unexpectedly, Pharmaceuticals Portfolio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Portfolio will offset losses from the drop in Pharmaceuticals Portfolio's long position.| Emerging Markets vs. T Rowe Price | Emerging Markets vs. Franklin Lifesmart 2045 | Emerging Markets vs. T Rowe Price | Emerging Markets vs. Nationwide Investor Destinations |
| Pharmaceuticals Portfolio vs. Fkhemx | Pharmaceuticals Portfolio vs. Fa 529 Aggressive | Pharmaceuticals Portfolio vs. Rbb Fund | Pharmaceuticals Portfolio vs. T Rowe Price |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |